FGF23 is a major regulator of phosphaturia and its gene expression in the bone is upregulated during acute and chronic kidney disease; however, the underlying mechanisms are complex and only partially understood (recently reviewed in Agoro and White, (2023)). This evidence concerns the gene FGF23 and chronic kidney disease.